DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J.
Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A.
J Thromb Haemost 2014;
12 (4) 488-496
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.